M Matthaei1, B Bachmann2, S Siebelmann2, C Cursiefen2. 1. Zentrum für Augenheilkunde, Universitätsklinik Köln, Kerpener Str. 62, 50924, Köln, Deutschland. mario.matthaei@uk-koeln.de. 2. Zentrum für Augenheilkunde, Universitätsklinik Köln, Kerpener Str. 62, 50924, Köln, Deutschland.
Abstract
BACKGROUND: Descemet membrane endothelial keratoplasty (DMEK) selectively removes diseased corneal endothelium and Descemet membrane and replaces them with healthy donor tissue. The DMEK technique represents the current gold standard for the treatment of corneal endothelial dysfunction. METHODS: In this article the surgical technique for DMEK is presented by means of a video. The indications for surgery, patient education, anesthesia and patient positioning, postoperative treatment as well as possible complications and their management are described. RESULTS: The DMEK can be applied for the treatment of a wide range of corneal endothelial disorders. In addition to the operative implementation, the basis for the outstanding results of the surgical procedure are careful donor-patient allocation, thorough examination and follow-up of all patients and experience of the surgeon. CONCLUSION: The use of DMEK is a safe and effective procedure for the treatment of corneal endothelial dysfunction. A standardized and individualized procedure provides the basis for optimal results compared to all previous transplantation procedures.
BACKGROUND: Descemet membrane endothelial keratoplasty (DMEK) selectively removes diseased corneal endothelium and Descemet membrane and replaces them with healthy donor tissue. The DMEK technique represents the current gold standard for the treatment of corneal endothelial dysfunction. METHODS: In this article the surgical technique for DMEK is presented by means of a video. The indications for surgery, patient education, anesthesia and patient positioning, postoperative treatment as well as possible complications and their management are described. RESULTS: The DMEK can be applied for the treatment of a wide range of corneal endothelial disorders. In addition to the operative implementation, the basis for the outstanding results of the surgical procedure are careful donor-patient allocation, thorough examination and follow-up of all patients and experience of the surgeon. CONCLUSION: The use of DMEK is a safe and effective procedure for the treatment of corneal endothelial dysfunction. A standardized and individualized procedure provides the basis for optimal results compared to all previous transplantation procedures.
Authors: S Siebelmann; B Bachmann; A Lappas; T Dietlein; M Hermann; S Roters; C Cursiefen; P Steven Journal: Ophthalmologe Date: 2016-08 Impact factor: 1.059
Authors: Michael Rudolph; Kathrin Laaser; Bjoern O Bachmann; Claus Cursiefen; Daniel Epstein; Friedrich E Kruse Journal: Ophthalmology Date: 2011-12-22 Impact factor: 12.079
Authors: Theofilos Tourtas; Ludwig M Heindl; Nikolaos Kopsachilis; Bjoern O Bachmann; Friedrich E Kruse; Claus Cursiefen Journal: Cornea Date: 2013-11 Impact factor: 2.651
Authors: Friedrich E Kruse; Kathrin Laaser; Claus Cursiefen; Ludwig M Heindl; Ursula Schlötzer-Schrehardt; Stephan Riss; Björn O Bachmann Journal: Cornea Date: 2011-05 Impact factor: 2.651
Authors: Mark A Greiner; Jordan J Rixen; Michael D Wagoner; Gregory A Schmidt; Christopher G Stoeger; Michael D Straiko; M Bridget Zimmerman; Anna S Kitzmann; Kenneth M Goins Journal: Cornea Date: 2014-11 Impact factor: 2.651
Authors: M Matthaei; S Schrittenlocher; D Hos; S Siebelmann; F Bucher; F Schaub; R Hoerster; R Siggel; S Roters; L M Heindl; B Bachmann; C Cursiefen Journal: Ophthalmologe Date: 2019-03 Impact factor: 1.059